MED-EL Cochlear Implant System
Med-El Corp. · Decision date Oct 9, 2026
What did the FDA approve?
The FDA record lists P000025/S136 for the MED-EL Cochlear Implant System as an approval dated 2026-10-09 under the 135 Review Track for 30-Day Notice, with the supplement reason given as Process Change - Manufacturer/Sterilizer/Packager/Supplier. The stated purpose is expanding the shelf-life of a raw material used to make the overmold of the MED-EL cochlear implants.
This is a supplement to PMA P000025, identified by the shared PMA number, and not an approval of a new device or of the full system. The record does not name the raw material, give the prior or new shelf-life, describe the overmold's function, or provide data on safety or clinical performance; the stated purpose is the agency's description of the change, not independent evidence of those outcomes.
FDA approval order statement
approval for expanding the shelf-life of a raw material used for making the overmold of the MED-EL cochlear implants
- Regulatory pathway
- PMA supplement
- Supplement type
- 135 Review Track For 30-Day Notice
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- Oct 9, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P000025/S136
- Regulatory pathway
- PMA supplement
- Applicant
- Med-El Corp.
- Product code
- MCM
- Decision code
- APPR
- Decision date
- Oct 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implant, cochlear.
- Applicant
- Med-El Corp.
- Product code
- MCM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P000025. Subsequent supplements may change the device or its indications.
FDA decision timeline
P000025 · Original PMA
COMBI 40+ COCHLEAR IMPLANT SYSTEM
P000025/S136 received
Application receipt date recorded by FDA.
P000025/S136 · FDA decision
135 Review Track For 30-Day Notice
Timeline entries are records held by MedtechLedger for P000025. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P000025
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Med-El Corp. | PMA approval | Aug 20, 2001 | FDA |
Explore the linked device profile
Other records with product code MCM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Nucleus 22 Cochlear Implant SystemP840024/S099 | Cochlear Americas | PMA supplement | Sep 28, 2026 | FDA |
Nucleus 22 Cochlear Implant SystemP890027/S067 | Cochlear Americas | PMA supplement | Sep 28, 2026 | FDA |
Nucleus 24 Cochlear Implant SystemP970051/S244 | Cochlear Americas | PMA supplement | Sep 28, 2026 | FDA |
CLARION MULTI-STRATEGY COCHLEAR IMPLANTP960058/S178 | Advanced Bionics | PMA supplement | Sep 18, 2026 | FDA |
HiResolution Bionic Ear SystemP960058/S177 | Advanced Bionics | PMA supplement | Sep 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Med-El Corp.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Furstenweg 77a, Innsbruck, 6020
Sources and methodology
- Original FDA record: P000025/S136
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



